AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions.
作者： Frank Rösch , Benedikt Klasen , Euy Sung Moon
DOI: 10.1016/J.NUCMEDBIO.2021.03.007
关键词:
摘要: … Coupling of AAZTA 5 -SA to the monoclonal antibody bevacizumab allowed for 177 Lu-… 177 Lu-labeling of sensitive biomolecules such as antibodies for theranostic applications. …
sci-hub.st 参考文章(70)
Jacques Barbet, Manuel Bardiès, Mickael Bourgeois, Jean-François Chatal, Michel Chérel, François Davodeau, Alain Faivre-Chauvet, Jean-François Gestin, Françoise Kraeber-Bodéré, Radiolabeled Antibodies for Cancer Imaging and Therapy Antibody Engineering. ,vol. 907, pp. 681- 697 ,(2012) , 10.1007/978-1-61779-974-7_38
Samir S Taneja, ProstaScint(R) Scan: Contemporary Use in Clinical Practice. Reviews in urology. ,vol. 6, ,(2004)
Eric W. Price, Brian M. Zeglis, Jacqueline F. Cawthray, Caterina F. Ramogida, Nicholas Ramos, Jason S. Lewis, Michael J. Adam, Chris Orvig, H4octapa-Trastuzumab: Versatile Acyclic Chelate System for 111In and 177Lu Imaging and Therapy Journal of the American Chemical Society. ,vol. 135, pp. 12707- 12721 ,(2013) , 10.1021/JA4049493
Lisa Bodei, Mark Kidd, Vikas Prasad, Irvin M. Modlin, Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors. Frontiers of Hormone Research. ,vol. 44, pp. 198- 215 ,(2015) , 10.1159/000402936
Snehlata, Arun Malhotra, Atul Sharma, Suhas Singla, Madhav Prasad Yadav, C S Bal, Atul Vasisht, Santosh Kumar Gupta, Parul Thakral, An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients. Indian Journal of Medical Research. ,vol. 139, pp. 544- 554 ,(2014)
Paul J. Bohdiewicz, Indium-111 Satumomab Pendetide: The First FDA-Approved Monoclonal Antibody for Tumor Imaging Journal of Nuclear Medicine Technology. ,vol. 26, pp. 155- 163 ,(1998)
Tanvir Rizvi, Chunli Deng, PatriceK Rehm, Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma World journal of nuclear medicine. ,vol. 14, pp. 209- 211 ,(2015) , 10.4103/1450-1147.163259
Henry Hongrong Cai, Risk Evaluation and Mitigation Strategy for Approved Therapeutic Antibodies MOJ Immunology. ,vol. 1, ,(2014) , 10.15406/MOJI.2014.01.00028
Eric W. Price, Chris Orvig, Matching chelators to radiometals for radiopharmaceuticals. Chemical Society Reviews. ,vol. 43, pp. 260- 290 ,(2014) , 10.1039/C3CS60304K
L Calabi, C Cavallotti, Eliana Gianolio, GB Giovenzana, P Losi, A Maiocchi, G Palmisano, Silvio Aime, [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Inorganic Chemistry. ,vol. 43, pp. 7588- 7590 ,(2004) , 10.1021/IC0489692